Riskpilot← Back to searchSign inGet full accessRAMBY MED AB
ABActiveOrg 5591916605Löt Ramby 14General medical practice activities · NACE 8621Est. 20191-4 employees
Revenue 2024
SEK 1,3M
-58% vs 2023
EBITDA margin
30.6%
-77% vs 2023
Equity ratio
61.9%
Financial strength
Net profit 2024
SEK -80K
-103% vs 2023
| Revenue | SEK 1,3M | -58% |
| EBITDA | SEK 412K | -77% |
| Net profit | SEK -80K | -103% |
| Total assets | SEK 8,3M | -1% |
| Equity | SEK 5,1M | -10% |
| Employees | — | — |
Legal name
RAMBY MED AB
Org number
5591916605
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 januari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinkonsult samt investmentbolag. Bolagets verksamhet består i uthyrning av medicinsk kompetens samt investering i noterade och eventuellt onoterade aktiebolag.
Address
Löt Ramby 14
Email
rambymed@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 287 | 1 969 | 1 493 | 3 201 | 1 347 |
| Staff expenses | — | — | −402 | −1 166 | −246 |
| EBITDA | 1 782 | 1 086 | 872 | 1 768 | 412 |
| Depreciation & amort. | −0 | −36 | −62 | −444 | −444 |
| EBIT | 1 782 | 1 050 | 810 | 1 324 | −32 |
| Net financials | 18 | 157 | 216 | 1 359 | −48 |
| Profit before tax | 1 831 | 1 207 | 1 026 | 2 683 | −80 |
| Tax | −391 | −253 | −254 | −353 | — |
| Net profit | 1 440 | 954 | 772 | 2 331 | −80 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 675 | 4 027 | 5 175 | 8 372 | 8 255 |
| Equity | 2 143 | 3 096 | 3 869 | 5 700 | 5 110 |
| Long-term debt | 0 | 0 | 906 | 1 950 | 2 970 |
| Short-term debt | 532 | 931 | 401 | 722 | 175 |
| Total debt | 532 | 931 | 1 306 | 2 672 | 3 145 |
EBITDA margin
30.6%
This company
15.8%
Market median
+94% vs market
20202024
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
-1.6%
This company
18.4%
Market median
-109% vs market
20202024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20202024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RAMBY MED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Wilhelm Danielsson | Board of Directors | 0 companies |
| Hans Folke Danielsson | Deputy Board Member | 0 companies |